Suppr超能文献

大鼠脑中μ和κ阿片受体亚型的增溶及初步表征

Solubilization and preliminary characterization of mu and kappa opiate receptor subtypes from rat brain.

作者信息

Chow T, Zukin R S

出版信息

Mol Pharmacol. 1983 Sep;24(2):203-12.

PMID:6310362
Abstract

The opiate agonists [3H]dihydromorphine (DHM, mu-selective ligand), [3H]bremazocine (potent kappa ligand), and [3H]etorphine bound stereospecifically, with high affinity, and reversibly to partially purified 3-(3-cholamidopropyl)dimethylammonio-1-propanesulfonate (CHAPS)-solubilized extract from rat brain membranes. Recoveries of the three binding activities were as follows: [3H]DHM, 47%; [3H]bremazocine, 55%; and [3H]etorphine, 17%. Each ligand exhibited (by Scatchard analysis) binding to a class of high-affinity sites (Kd = 0.8-2 nM). Hill analyses revealed Hill coefficients of n = 1.1-1.3. Many of the properties of solubilized brain opiate receptors are similar to those of membrane-associated opiate receptors. Opiate binding in soluble fractions was inhibited by a variety of protein-modifying agents, including trypsin, proteinase K, and N-ethylmaleimide as well as by heat treatment (60 degrees, 15 min). The relative potencies of a series of opiate narcotic agonists and antagonists in displacing 2 nM [3H]etorphine binding to the CHAPS-solubilized extract was similar to that determined for rat brain homogenates. In contrast, D-Ala2, D-Leu5-enkephalin (DADLE, putative delta-selective ligand) exhibited a much lower affinity for solubilized brain opiate receptors than for the membrane-bound receptors unless assayed in the presence of manganese chloride, sodium chloride, and GTP. Mu agonist binding to solubilized receptors was inhibited relatively selectively by sodium and guanyl nucleotides. These findings lend support to the pharmacological relevance of the solubilized opiate-binding component(s). The pI of the solubilized brain opiate receptor(s) was estimated by liquid isoelectrofocusing to be pH 4. The sizes of the solubilized, prelabeled [3H]etorphine-receptor complex of the solubilized mu and kappa receptor subtypes, as assayed by stereospecific binding of [3H]DHM and [3H]bremazocine binding, respectively, were estimated by molecular exclusion chromatography. The [3H]etorphine-receptor complex migrated as a broad radioactive peak at a position corresponding to a protein of Stoke radius 63 A. A secondary peak of radioactivity was observed at the salt peak. Mu receptor activity chromatographed as two major peaks. The first of these eluted just behind, but significantly separated from, the protein void peak and corresponded to a Stokes radius of 70 A; the second eluted just ahead of the salt peak and corresponded to a radius of less than 20 A. Kappa receptor activity eluted at positions corresponding to macromolecules of 50 A and less than or equal to 20 A. Together, these findings indicate that selective mu and kappa ligands interact with high molecular weight species of somewhat different sizes as well as a lower molecular weight species, which may represent a common subunit that can bind both ligands.

摘要

阿片类激动剂[3H]二氢吗啡(DHM,μ选择性配体)、[3H]布瑞马唑辛(强效κ配体)和[3H]埃托啡能立体特异性、高亲和力且可逆地与大鼠脑膜经部分纯化的3-(3-胆酰胺丙基)二甲基铵-1-丙烷磺酸盐(CHAPS)增溶提取物结合。三种结合活性的回收率如下:[3H]DHM为47%;[3H]布瑞马唑辛为55%;[3H]埃托啡为17%。每种配体(通过Scatchard分析)均显示与一类高亲和力位点结合(解离常数Kd = 0.8 - 2 nM)。Hill分析显示Hill系数n = 1.1 - 1.3。增溶脑阿片受体的许多特性与膜相关阿片受体的特性相似。可溶性组分中的阿片结合受到多种蛋白质修饰剂的抑制,包括胰蛋白酶、蛋白酶K、N-乙基马来酰亚胺以及热处理(60℃,15分钟)。一系列阿片类麻醉激动剂和拮抗剂在取代2 nM [3H]埃托啡与CHAPS增溶提取物结合时的相对效力与在大鼠脑匀浆中测定的相似。相比之下,D-Ala2,D-Leu5-脑啡肽(DADLE,假定的δ选择性配体)对增溶脑阿片受体的亲和力比对膜结合受体的亲和力低得多,除非在氯化锰、氯化钠和鸟苷三磷酸存在下进行测定。μ激动剂与增溶受体的结合相对选择性地受到钠和鸟苷核苷酸的抑制。这些发现支持了增溶阿片结合成分的药理学相关性。通过液相等电聚焦估计增溶脑阿片受体的等电点为pH 4。分别通过[3H]DHM和[3H]布瑞马唑辛结合的立体特异性结合测定,增溶的μ和κ受体亚型的预标记[3H]埃托啡-受体复合物的大小通过分子排阻色谱法进行估计。[3H]埃托啡-受体复合物以一个宽的放射性峰迁移,其位置对应于斯托克斯半径为63 Å的蛋白质。在盐峰处观察到一个放射性二级峰。μ受体活性经色谱分离为两个主要峰。其中第一个峰在蛋白质空体积峰之后但明显分离处洗脱,对应于斯托克斯半径为70 Å;第二个峰在盐峰之前洗脱,对应半径小于20 Å。κ受体活性在对应于50 Å及小于或等于20 Å的大分子的位置洗脱。总之,这些发现表明选择性μ和κ配体与大小略有不同的高分子量物种以及较低分子量物种相互作用,较低分子量物种可能代表一种可结合两种配体的共同亚基。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验